Supernus Pharmaceuticals, Inc.
SUPN
$44.88
$1.563.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.52% | 55.71% | 77.97% | 101.41% | 128.93% |
| Total Receivables | -7.65% | -1.42% | -1.44% | 2.57% | 11.67% |
| Inventory | -35.41% | -34.17% | -29.86% | -23.36% | -24.74% |
| Prepaid Expenses | 35.61% | 21.70% | 116.41% | 14.53% | -48.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.02% | 26.32% | 39.13% | 42.43% | 39.54% |
|
|
|||||
| Total Current Assets | 25.02% | 26.32% | 39.13% | 42.43% | 39.54% |
| Net Property, Plant & Equipment | -17.71% | -20.26% | -15.29% | -12.01% | -7.60% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -14.00% | -13.39% | -13.00% | -15.75% | -15.51% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.95% | -24.60% | -17.17% | -19.26% | -13.06% |
| Total Assets | 5.06% | 3.31% | 7.08% | 4.48% | 1.76% |
|
|
|||||
| Total Accounts Payable | 77.51% | -50.88% | 133.55% | 88.61% | 5.18% |
| Total Accrued Expenses | 6.57% | 7.94% | 8.39% | -1.63% | 9.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -23.67% | -34.99% | -17.31% | 8.81% | 20.75% |
| Total Finance Division Other Current Liabilities | -32.64% | -29.72% | -11.38% | 3.05% | 52.02% |
| Total Other Current Liabilities | -32.64% | -29.72% | -11.38% | 3.05% | 52.02% |
| Total Current Liabilities | -7.22% | -10.42% | 0.76% | 1.38% | 22.20% |
|
|
|||||
| Total Current Liabilities | -7.22% | -10.42% | 0.76% | 1.38% | 22.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.51% | -20.08% | -17.51% | -14.52% | -11.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.04% | -69.15% | -61.66% | -70.70% | -77.52% |
| Total Liabilities | -11.13% | -15.56% | -6.69% | -10.03% | -3.97% |
|
|
|||||
| Common Stock & APIC | 9.18% | 8.78% | 9.09% | 7.86% | 7.28% |
| Retained Earnings | 12.83% | 12.83% | 15.31% | 12.40% | 1.05% |
| Treasury Stock & Other | 46.24% | 70.22% | 68.13% | 106.47% | 79.04% |
| Total Common Equity | 11.12% | 10.93% | 12.39% | 10.41% | 4.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.12% | 10.93% | 12.39% | 10.41% | 4.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.12% | 10.93% | 12.39% | 10.41% | 4.08% |
|
|
|||||